Trial Profile
R788 as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2014
Price :
$35
*
At a glance
- Drugs Fostamatinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 30 Jun 2014 New trial record